Antioxidants in biology and medicine : (Record no. 89834)

MARC details
000 -LEADER
fixed length control field 04741cam a2200541 i 4500
001 - CONTROL NUMBER
control field ocn730515000
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20221128211338.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr |||||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 100924s2011 nyua ob 001 0 eng
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2020679850
040 ## - CATALOGING SOURCE
Original cataloging agency DLC
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781612094663
Qualifying information ebook
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 161209466X
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9781611225020
Qualifying information hardcover
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 1611225027
035 ## - SYSTEM CONTROL NUMBER
System control number 368646
-- (N$T)
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)730515000
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QV 325
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 037000
Source bisacsh
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Antioxidants in biology and medicine :
Subtitle essentials, advances, and clinical applications
Statement of responsibility, etc
Medium [E-Book]
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Hauppauge, N.Y. :
Name of producer, publisher, distributor, manufacturer Nova Science Publishers,
Date of production, publication, distribution, manufacture, or copyright notice c2011.
300 ## - PHYSICAL DESCRIPTION
Physical description 1 online resource
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - CONTENTS
Contents ANTIOXIDANTS IN BIOLOGY AND MEDICINE: ESSENTIALS, ADVANCES, AND CLINICAL APPLICATIONS ; ANTIOXIDANTS IN BIOLOGY AND MEDICINE: ESSENTIALS, ADVANCES, AND CLINICAL APPLICATIONS ; Contents; Preface ; SECTION I INTRODUCTION TO OXIDATIVE STRESS AND ANTIOXIDANTS ; Introduction to Oxidative Stress; Abstract ; 1. Historical Overview ; 2. Free Radicals and Reactive Oxygen and Nitrogen Species (ROS/RNS) ; 2.1. Definitions ; 2.1.1. Free Radicals ; 2.1.2. ROS/RNS ; 2.2. Sources of ROS/RNS ; 2.2.1. Endogenous Sources ; 2.2.1.1. NAD(P)H OXIDASES ; 2.2.1.2. MITOCHONDRIA.
505 8# - CONTENTS
Contents 2.2.1.3. OTHER ENDOGENOUS SOURCES 2.2.2. Exogenous Sources; 2.2.2.1. PHYSICAL AGENTS AND PARTICULATE MATTER ; 2.2.2.2. XENOBIOTICS ; 2.2.2.3. BIOLOGIC AGENTS; 2.3. Chemical Reactivity of Major Types of ROS/RNS; 2.3.1. Superoxide (O2.- ) ; 2.3.2. Hydrogen Peroxide (H2O2) ; 2.3.3. Hydroxyl Radical (. OH) ; 2.3.4. Peroxynitrite (ONOO- ) ; 2.3.5. Nitric Oxide (. NO) and Related Nitrogen Oxides ; 2.3.6. Peroxyl Radical (LOO.) and Alkoxyl Radical (LO.) ; 2.3.7. Singlet Oxygen (1O2) ; 2.3.8. Hypochlorous Acid (HOCl) ; 2.3.9. Ozone (O3) ; 2.4. Molecular Targets of ROS/RNS and Cellular Consequences.
505 8# - CONTENTS
Contents 3. Oxidative Stress and Diseases3.1. Definitions ; 3.1.1. Oxidative Stress ; 3.1.2. Other Related Terms ; 3.2. Oxidative Stress in Diseases ; 3.2.1. Different Roles of Oxidative Stress in Diseases; 3.2.2. Diseases Involving an Oxidative Stress Mechanism ; 4. Conclusion ; 5. References; Introduction to Antioxidants ; Abstract ; 1. Definition and Mode of Antioxidant Action ; 2. Classification of Antioxidants; 3. Antioxidant Gene Regulation ; 3.1. Regulation of Antioxidant Gene Expression by Nrf2 Signaling ; 3.1.1. Historical Overview ; 3.1.2. Keap1-Nrf2-ARE Signaling.
505 8# - CONTENTS
Contents 3.1.3. Nrf2-regulated Antioxidants 3.2. Nrf2-dependent Induction of Antioxidants and Protection against Oxidative Stress ; 4. Antioxidant-based Disease Intervention; 4.1. Overall Strategies of Antioxidant-based Disease Intervention ; 4.2. Animal Studies on Antioxidant-based Disease Intervention ; 4.3. Human Studies on Antioxidant-based Disease Intervention ; 5. Caveats on Antioxidants and Antioxidant-based Disease Intervention ; 5.1. Multiple Biological Activities of Antioxidants; 5.2. Genetic Manipulations of Antioxidants ; 6. Conclusion ; 7. References.
505 8# - CONTENTS
Contents SECTION II ANTIOXIDANTS SYNTHESIZED BY CELLS Superoxide Dismutase ; Abstract ; 1. Overview ; 1.1. Definition and History ; 1.2. Basic Characteristics ; 2. Biochemistry and Molecular Regulation ; 2.1. Biochemistry ; 2.2. Molecular Regulation; 3. Role in Health and Disease; 3.1. Animal Studies ; 3.1.1. Experimental Approaches ; 3.1.2. Role in Cardiovascular Diseases ; 3.1.3. Role in Diabetes ; 3.1.4. Role in Neurological Diseases ; 3.1.5. Role in Pulmonary Diseases ; 3.1.6. Role in Hepatic and Gastrointestinal Diseases; 3.1.7. Role in Renal Diseases ; 3.1.8. Role in Skin Diseases.
590 ## - LOCAL NOTE (RLIN)
Local note Master record variable field(s) change: 050, 082
650 #0 - SUBJECT HEADINGS
Subject term Antioxidants.
9 (RLIN) 5243
650 #0 - SUBJECT HEADINGS
Subject term Active oxygen.
650 02 - SUBJECT HEADINGS
Subject term Antioxidants.
9 (RLIN) 5243
700 1# - ADDED PERSONAL NAME
Added personal author Li, Yunbo.
856 40 - ONLINE RESOURCE
Uniform Resource Identifier <a href="https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=368646">https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=368646</a>
Link text Kingston Hospital NHS Foundation Trust OpenAthens account holders click here for access
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Suppress in OPAC Do not Suppress in OPAC
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Description based on print version record.
938 ## -
-- YBP Library Services
-- YANK
-- 6940649
938 ## -
-- EBSCOhost
-- EBSC
-- 368646
938 ## -
-- ebrary
-- EBRY
-- ebr10662979
938 ## -
-- ProQuest Ebook Central
-- EBLB
-- EBL3019172
994 ## -
-- 92
-- N$T
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Source of acquisition Total Checkouts Date last seen Uniform Resource Identifier Price effective from Koha item type
        Stenhouse Library Stenhouse Library   28/11/2022 eBook EBSCO clinical collection   28/11/2022 https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=368646 28/11/2022 Electronic book
London Health Libraries Koha Consortium privacy notice